Skip to main content
. 2020 Jan 17;10:1561. doi: 10.3389/fphar.2019.01561

Figure 6.

Figure 6

Gaudichaudione H (GH) suppressed the toll-like receptor 4 (TLR4)-myeloid differentiation primary response 88 (MyD88) pathway in activated RAW 264.7 cells and bone marrow-derived macrophages (BMDMs). Cells were pretreated with GH and then stimulated for 15 min in RAW 264.7 cells (A) and BMDMs (B). Protein samples were analyzed using Western blot with specific antibodies. The values above the bands mean the relative band intensities. β-Actin was used as an internal control. Data were from three independent experiments.